医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Tumor-educated cells in tumor microenvironment:Key drivers of immunotherapy resistance

摘要In the past decade,immunotherapies targeting cytotoxic T-lymphocyte antigen-4(CTLA-4),programmed cell death 1(PD-1),and PD-1 ligand(PD-L1)have been approved for solid tumors.However,some patients demonstrate suboptimal clinical outcomes due to resistance.The tumor microenvironment(TME)significantly affects the efficiency of immunotherapy by mediating interactions between tumor and non-tumor cells,including dendritic cells,T cells,B cells,macrophages,neutrophils,NK cells,and myeloid-derived suppressor cells(MDSCs).These non-tumor cells often exhibit two phenotypes with altered functions,and tumor cells drives their transition towards tumor promotion through tumor-education.Tumor-educated cells(TECs)are cells influenced by tumor cells,which acquire immune-suppressive phenotypes and promote tumor progression through resistance to anti-cancer therapies.These cells undergo modifications in response to signals from the tumor,which can influence their roles in tumor progression.Their dynamic interactions with tumor cells contribute to the reshaping of the TME,facilitating cancer growth and immune modulation.This review summarizes research on TECs in TME,explores mechanisms related to tumor education,and discusses their role in tumor progression and immunotherapy resistance.Additionally,potential therapeutic approaches targeting these cells are also reviewed,which may complement current treatment strategies.

更多
广告
作者 Ji'an Zou [1] Shuxing Wang [1] Yingzhe Zhang [1] Wentao Tian [2] Ge Mai [3] Yiting Xu [3] Wenjie Xiao [3] Edward E.Graves [4] Fang Wu [5] 学术成果认领
作者单位 Department of Oncology,the Second Xiangya Hospital,Central South University,Changsha 410011,China [1] Department of Oncology,the Second Xiangya Hospital,Central South University,Changsha 410011,China;Xiangya School of Medicine,Central South University,Changsha 410013,China [2] Xiangya School of Medicine,Central South University,Changsha 410013,China [3] Department of Radiation Oncology,Stanford University,Stanford,CA 94305,USA [4] Department of Oncology,the Second Xiangya Hospital,Central South University,Changsha 410011,China;Department of Radiation Oncology,Stanford University,Stanford,CA 94305,USA;Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre,Changsha 410082,China;Hunan Key Laboratory of Tumor Models and Individualized Medicine,the Second Xiangya Hospital,Central South University,Changsha 410011,China;Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer,the Second Xiangya Hospital,Central South University,Changsha 410011,China [5]
栏目名称
DOI 10.21147/j.issn.1000-9604.2025.03.12
发布时间 2025-08-11(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览0
  • 下载2
中国癌症研究(英文版)

中国癌症研究(英文版)

2025年37卷3期

中插63,446-465,中插64页

SCIMEDLINEISTICCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷